论文部分内容阅读
目的：探讨温阳方联合西药治疗慢性心力衰竭（ CHF）的临床疗效。方法70例CHF 患者随机分温阳方＋西药治疗组35例（试验组）和西药治疗组35例（对照组）。对照组给予降血压、β受体阻滞剂、利尿剂、强心等药物治疗；试验组在对照组的基础上予以温阳方，2组患者治疗1个月。治疗1个月后评价2组患者神经内分泌指标及左室射血分数（LVEF）。结果治疗1个月后，试验组与对照组血浆去甲肾上腺素（NE）、血管紧张素Ⅱ（AngⅡ）和醛固醇（ALD）均明显降低（P ＜0．05），左室射血分数（LVEF）均显著升高（P ＜0．05），但试验组与对照组相比变化更为显著（P ＜0．05）。治疗后试验组总有效率显著高于对照组（P ＜0．05）。结论温阳方联合西药治疗CHF 可显著提高LVEF，改善心力衰竭症状。“,”Objective To evaluate the clinical effects of Wenyang in the treatment of chronic heart failure ( CHF ) .Methods Seventy patients with CHF were recruited and randomly divided into experiment group ( n=35 ) and control group ( n=35 ) .Patients in the experiment group were treated with Wenyangfang and west medicine;patients in the control group were treated with west medicine only.All the patients were treated 1 month.After 1 month treatment, the neuroendocrine indicators and LVEF were compared between the two groups.Results After treatment of 1 month, the norepinephrine, angiotensin Ⅱ( AngⅡ) , aldosterone ( ALD ) were decreased in both experiment and control group ( P <0.05), the left ventricular ejection fraction(LVEF) was both improved in the two groups.And the experiment group was much significant than that of control group ( P <0.05 ) .The total efficacy in the experiment group was much higher than that of control group ( P <0.05 ) . Conclusion Wenyangfang combined with the medicine can significant improve the LVEF and symptom in patients with CHF.